Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Miami, Florida · 10845 NW 7TH ST, APT 22, MIAMI, FL 33172-3778 · (786) 447-3091
Part of Exelixis Clinical
As of July 2026, 2 paid clinical trials are recruiting at Exelixis Clinical in Miami, Florida. Active studies at this site cover conditions such as Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Urothelial Carcinoma (UC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (2)
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for Acne
79 locations incl. Scottsdale
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All·Age: 18 - 45
Code: NCT06316297·Phase 1, Phase 2·Recruiting·Listed Mar 2024
More research sites in Miami
- University of Miami (258 trials)
- University of Miami Miller School of Medicine-Sylvester Cancer Center (76 trials)
- Nicklaus Children's Hospital (57 trials)
- Miami Cancer Institute (43 trials)
- UM Sylvester Comprehensive Cancer Center at Kendall (32 trials)
- Sylvester Comprehensive Cancer Center (28 trials)
- GSK Investigational Site (19 trials)
- University of Miami Miller School of Medicine (19 trials)
- Miami Cancer Institute at Baptist Health, Inc. (17 trials)
- Bascom Palmer Eye Institute (16 trials)